Researchers In Israel Develop Cannabis Inhaler Specifically For Cancer Patients
Wednesday, March 27, 2019 IST
In many countries, the cultivation and use of marijuana hold a stigma. Within the next week, this will no longer be the case in Israel. Researchers with pharmaceutical companies are taking advantage of increased access to marijuana by studying the plant’s uses and effects. For example, clinical research has already begun on a cannabis inhaler which may offer safe and immediate relief to cancer patients.
The method of delivering cannabis concentrates through an inhaler will increase accessibility for cancer patients who are treated with long-term pharmaceutical cannabis (for instance, sublingual tablets). The new method of delivery may also benefit those suffering from acute cancer pain, or who prefer to avoid smoking cannabis.
“Every piece of clinical research that helps manage treatment using medical cannabis is important. Delivering treatment via inhalation is characterized by a quicker response time than oral or sublingual tablets,” said Dr. Itay Gur-Aryeh, Director of the Pain Unit at Sheba Hospital, Tel Hashomer.
The vaporizer is outfitted with an attached vaporizer, to which a cancer patient can add a preferred, measured dose of cannabis extract. The extract includes a precise dose of active ingredients, which are then inhaled. The method of ingestion is ideal for cancer patients who are edible for treatment with medical cannabis. The research is being led by Rafa and Panaxia, two Israeli-based pharmaceutical companies.
According to a press release, Panaxia announced a clinical trial for registration purposes at the Ministry of Health to examine the biological availability of delivering medical cannabis via a metered-dose inhaler. The advanced medical products are marketed by Rafa Pharmaceuticals and will be tested as part of the clinical trial. If all goes according to plan, the medical cannabis inhalers may be available in Israeli pharmacies within the year.
”The clinical trial is performed as part of the registration procedure of the new products which we are about to launch in Israel this year, in collaboration with Rafa,” said Dr. Dadi Segal, Panaxia CEO. “Through access to cannabis inhalers, and subject to a medical specialist’s recommendation, we strive to help more patients suffering from acute pain. The inhaler will provide patients that are unable or unwilling to smoke, the right to be treated consistently and precisely.”
“This innovative product is an additional method of delivery of medical cannabis products which we are intending to launch. The future of treatment with medical cannabis is the ability to match treatment to each patient in the best possible way,” Anat Savion, Rafa CEO, added.
Related Topics
Trending News & Articles
ALMATY: Hour upon hour, day upon day, Omir Bekali and other detainees in far western China's new indoctrination camps had to disavow the...
Recently posted . 217K views . 1 min read
If you have payed attention to the belly buttons of people on the beach or the members of your family, you have probably noticed that they have different shapes and...
Recently posted . 10K views . 2 min read
The Langya henipavirus has a place with a similar group of infections, including Nipah, which is known to kill up to 3/4 of people in extreme cases.
Recently posted . 6K views . 1 min read
Queen's death: The eldest of her four children, Charles, Prince of Wales, who at 73 was the oldest heir apparent in British history, became king immediately...
Recently posted . 5K views . 1 min read
More in Food & Health
Chinese sellers are stuffing sea-animals like turtle and fish inside tiny plastic bags with water and selling these as keychains. And while various shopkeepers clai...
Recently posted. 1K views . 2 min read
CANADA GOVERNMENT IS SUPPORTIVE
Recently posted. 731 views . 0 min read
The neural network model that directly analysed the ECG signals was found to be superior for predicting one-year risk of death.
Recently posted. 865 views . 0 min read
Recently posted . 1K views
Recently posted . 1K views
Recently posted . 2K views
Recently posted . 2K views
Recently posted . 4K views . 52 min read
Recently posted . 4K views . 67 min read
A new study published Thursday in the journal Current Biology found the influential excrement supported thriving communities of mosses and lichens, which in turn su...
Recently posted. 934 views . 2 min read
PERTH: Qantas on Saturday launched the first non-stop passenger service linking Australia and Europe, with a Boeing 787 Dreamliner departing Perth ...
Recently posted. 910 views . 1 min read